Epigenomics (ECX) Stock Statistics & Valuation Metrics

Epigenomics has a market cap or net worth of €762.95K. The enterprise value is €11.36M.

Epigenomics has 876,949 shares outstanding. The number of shares has decreased by -2.65% in one year.

Epigenomics’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is -33.79%.

The current PE Ratio of Epigenomics is ―. Epigenomics’s PEG ratio is 0.00547.

In the last 12 months, Epigenomics had revenue of 339.00K and earned -4.46M in profits. Earnings per share was -5.23.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Epigenomics pays an annual dividend of ―, resulting in a dividend yield of ―

Epigenomics upcoming earnings date is Aug 12, 2026, TBA (Confirmed).

Epigenomics as a current ratio of 5.27, with Debt / Equity ratio of ―

In the past 12 months, Epigenomics has paid 0.00 in taxes.

Epigenomics EV to EBITDA ratio is -4.02, with an EV/FCF ratio of -1.99.

Epigenomics has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of -1232.15%, and net profit margin of -1316.81%.

The average price target for Epigenomics is ―, which is 11.43% higher than the current price. The consensus rating is ―